Joe Chan

Calculated cardiovascular risk after conversion from calcineurin inhibitor to belatacept in kidney transplant recipients: A randomized controlled trial

A. Hartmann, A. Jardine, H. Holdaas, 2022 .

A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients

A. Åsberg, H. Holdaas, S. Bergan, 2019, Therapeutic drug monitoring.

Associations of Serum Uromodulin and Urinary Epidermal Growth Factor with Measured Glomerular Filtration Rate and Interstitial Fibrosis in Kidney Transplantation

I. Eide, T. Jenssen, M. Svensson, 2022, American Journal of Nephrology.

Marine n-3 fatty acid consumption in a Norwegian renal transplant cohort: Comparison of a food frequency questionnaire with plasma phospholipid marine n-3 levels

I. Eide, T. Jenssen, E. Schmidt, 2020, PloS one.

Secreted PDZD2 exerts an insulinotropic effect on INS-1E cells by a PKA-dependent mechanism

K. Yao, Danny Hon-Fai So, M. Tsui, 2020, Molecular and Cellular Endocrinology.

Marine n-3 Polyunsaturated Fatty Acids and Cellular Senescence Markers in Incident Kidney Transplant Recipients: The Omega-3 Fatty Acids in Renal Transplantation (ORENTRA) Randomized Clinical Trial

I. Eide, T. Jenssen, M. Svensson, 2021, Kidney medicine.

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

J. D. de Fijter, A. Hartmann, A. V. van Zonneveld, 2022, Kidney medicine.